Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mardor

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
AJNR. American Journal of Neuroradiology|July 9, 2016
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade GliomasD Daniels, D Guez, D Last, et al.
The Review of Scientific Instruments|June 2, 2014
Note: Proton irradiation at kilowatt-power and neutron production from a free-surface liquid-lithium targetS Halfon, A Arenshtam, D Kijel, et al.
Journal of Applied Toxicology : JAT|August 24, 2011
Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatmentYossi Rosman, Arik Eisenkraft, Amir Krivoy, et al.
Aging Cell|August 7, 2018
High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse modelShirin Elhaik Goldman, David Goez, David Last, et al.
Journal of Neuro-Oncology|June 21, 2021
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade gliomaKeren Porper, Yael Shpatz, Luba Plotkin, et al.
Frontiers in Neurology|January 9, 2019
A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of GlioblastomaEfrat Shavit-Stein, Ehud Sheinberg, Valery Golderman, et al.
Frontiers in Microbiology|December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions <i>in vitro</i>, and safety for application to COVID-19 patients in a pilot clinical studyAvraham Abutbul, Helena Mumblat, Yaara Porat, et al.
Neuro-Oncology|January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trialJohn H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Biomaterials|August 5, 2021
Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro studyShahar Shelly, Sigal Liraz Zaltsman, Ofir Ben-Gal, et al.
Neuro-Oncology|December 3, 2014
Delayed contrast extravasation MRI: a new paradigm in neuro-oncologyLeor Zach, David Guez, David Last, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
AJNR. American Journal of Neuroradiology|July 9, 2016
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade GliomasD Daniels, D Guez, D Last, et al.
The Review of Scientific Instruments|June 2, 2014
Note: Proton irradiation at kilowatt-power and neutron production from a free-surface liquid-lithium targetS Halfon, A Arenshtam, D Kijel, et al.
Journal of Applied Toxicology : JAT|August 24, 2011
Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatmentYossi Rosman, Arik Eisenkraft, Amir Krivoy, et al.
Aging Cell|August 7, 2018
High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse modelShirin Elhaik Goldman, David Goez, David Last, et al.
Journal of Neuro-Oncology|June 21, 2021
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade gliomaKeren Porper, Yael Shpatz, Luba Plotkin, et al.
Frontiers in Neurology|January 9, 2019
A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of GlioblastomaEfrat Shavit-Stein, Ehud Sheinberg, Valery Golderman, et al.
Frontiers in Microbiology|December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions <i>in vitro</i>, and safety for application to COVID-19 patients in a pilot clinical studyAvraham Abutbul, Helena Mumblat, Yaara Porat, et al.
Neuro-Oncology|January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trialJohn H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Biomaterials|August 5, 2021
Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro studyShahar Shelly, Sigal Liraz Zaltsman, Ofir Ben-Gal, et al.
Neuro-Oncology|December 3, 2014
Delayed contrast extravasation MRI: a new paradigm in neuro-oncologyLeor Zach, David Guez, David Last, et al.
Pageof 8